Search filters

List of works by Corey A. Carter

A Case of Paraneoplastic Cushing Syndrome Presenting as Hyperglycemic Hyperosmolar Nonketotic Syndrome

scientific article

A Partial Response to Reintroduced Chemotherapy in a Resistant Small Cell Lung Cancer Patient After Priming with RRx-001.

scientific article

A Prognostic Model to Predict Mortality among Non-Small-Cell Lung Cancer Patients in the U.S. Military Health System

scientific article

A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis

scientific article published on 23 April 2018

A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

scientific article published on 27 February 2012

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

scientific article

A practical guide to the handling and administration of personalized transcriptionally attenuated oncolytic adenoviruses (PTAVs)

scientific article published on 23 July 2018

Addressing the elephant in the room, therapeutic resistance in non-small cell lung cancer, with epigenetic therapies

scientific article

Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells.

scientific article

CMET-46. INITIAL CLINICAL AND ADVANCED IMAGING OUTCOMES FROM A MULTI-INSTITUTIONAL PHASE I DOSE-ESCALATION TRIAL OF RRX-001 PLUS WHOLE BRAIN RADIATION FOR PATIENTS WITH BRAIN METASTASES

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-Distance

scientific article

Conversion of Platinum-Etoposide-Resistant to Sensitive SCLC after Treatment with the Epi-Immunotherapeutic RRx-001: A Case Report.

scientific article published on 19 September 2016

Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management

scientific article published on 20 July 2017

Episensitization: Defying Time's Arrow

scientific article published on 11 June 2015

Extended treatment with MY-NEOVAX, personalized neoantigen-enhanced oncolytic viruses, for two end-stage cancer patients

scientific article published on 01 November 2019

Flushing Out Carcinoid Syndrome: Beneficial Effect of the Anticancer Epigenetic Agent RRx-001 in a Patient with a Treatment-Refractory Neuroendocrine Tumor

scientific article

Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response

scientific article

Immune Reactivity and Pseudoprogression or Tumor Flare in a Serially Biopsied Neuroendocrine Patient Treated with the Epigenetic Agent RRx-001.

scientific article published on January 2016

Just eat it: A review of CD47 and SIRP-α antagonism

scientific article published on 30 May 2020

Medical Machiavellianism: the tradeoff between benefit and harm with targeted chemotherapy

scientific article published on 22 January 2016

Metformin use and survival after non-small cell lung cancer: A cohort study in the US Military health system

scientific article published on 05 April 2017

Navigating the "No Man's Land" of TKI-Failed EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): A Review.

scientific article

No patient left behind: The promise of immune priming with epigenetic agents

scientific article published on 30 August 2017

Partial Response in an RRx-001-Primed Patient with Refractory Small-Cell Lung Cancer after a Third Introduction of Platinum Doublets.

scientific article published on 24 May 2016

Partial Response to Platinum Doublets in Refractory EGFR-Positive Non-Small Cell Lung Cancer Patients after RRx-001: Evidence of Episensitization

scientific article published on 28 January 2016

Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC.

scientific article published on 24 April 2016

Pulmonary Tumor Thrombotic Microangiopathy: A New Paraneoplastic Syndrome?

scientific article published on January 2016

REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer

scientific article published on 11 September 2019

RRx-001 Priming of PD-1 Inhibition in the Treatment of Small Cell Carcinoma of the Vagina: A Rare Gynecological Tumor.

scientific article

RRx-001 in Refractory Small-Cell Lung Carcinoma: A Case Report of a Partial Response after a Third Reintroduction of Platinum Doublets

scientific article published on January 2016

RRx-001 protects against cisplatin-induced toxicities.

scientific article published on 17 April 2017

RRx-001, a novel clinical-stage chemosensitizer, radiosensitizer, and immunosensitizer, inhibits glucose 6-phosphate dehydrogenase in human tumor cells

scientific article

RRx-001-Induced Tumor Necrosis and Immune Cell Infiltration in an EGFR Mutation-Positive NSCLC with Resistance to EGFR Tyrosine Kinase Inhibitors: A Case Report

scientific article published on 15 January 2016

RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials

scientific article published on 9 December 2016

Rationale and necessity for delivery of RRx-001, a Myc and CD47 antagonist, by intravenous blood mix

scientific article published on 24 April 2020

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.

scientific article published on 19 August 2015

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

scientific article

Superior Vena Cava Syndrome in a Patient with Small-Cell Lung Cancer: A Case Report

scientific article published on January 2017

Survival and Racial Differences of Non-Small Cell Lung Cancer in the United States Military

scientific article

TGF-beta: a master immune regulator

scientific article published on 12 April 2020

The Case of a Zebra That Was Misdiagnosed as a Horse: Pulmonary Tumor Thrombotic Microangiopathy, a New Paraneoplastic Syndrome, Mimicking PD-1-Induced Pneumonitis

scientific article published on 27 January 2016

The Development Of RRx-001, A Novel Nitric-Oxide-Mediated Epigenetically Active Anticancer Agent.

scientific article published in August 2015

The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury

scientific article published on 27 April 2017

The war on cancer: a military perspective

scientific article

Treatment of nonsmall cell lung cancer: overcoming the resistance to epidermal growth factor receptor inhibitors

scientific article published on March 2012

Turning on the Radio: Epigenetic Inhibitors as Potential Radiopriming Agents

scientific article

What's New in SCLC? A Review

scientific article published on 6 September 2017

Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial

scientific article published on April 2016

Paulina is supported by:

About Paulina

Help